DRG Epidemiology’s coverage of gout comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of gout for each country, as well as annualized case counts projected to the national population.
Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets and 10 years for the other countries covered in this report.
DRG Epidemiology’s gout forecast will answer the following questions:
In developing countries, what impact will economic growth and development have on the number of people living with a diagnosis of gout?
How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of gout over the forecast period?
All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is provided for full transparency into research and methods.
In addition to the total number of cases for each forecast year, DRG Epidemiology provides at least ten years of forecast data for the following gout subpopulations:
Prevalence of Gout per 1,000 Among People Aged 20+ in 2019 and 2029ttttttttt
Relative Sizes of the Factors Contributing to the Trend in Prevalent Cases of Gout over the Next Ten Yearsttttttttt
Number of Additional Prevalent Cases of Gout in 2029 in the Countries Under Study due to Trends in Risk or Survivaltttttttttttttttt
Epidemiology Data
Methods
Total Prevalence
Diagnosed 12-Month Prevalent Cases
Acute Gout Events
Diagnosed 12-Month Incident Cases
Lifetime DALYs Gained
Reference Materials
Literature Review
Studies Included in the Analysis of Gout
Studies Excluded from the Analysis of Gout
Risk/Protective Factors
Risk/Protective Factors for Gout
Bibliography
Abey John, M.P.H.
Abey John, M.P.H., is an epidemiologist at DRG, part of Clarivate. Prior to joining DRG, he worked with Jhpiego (an affiliate of Johns Hopkins Medical University) in implementing family planning health programs in India in collaboration with the government of India. He also has worked at the grassroots level as a health team manager to help the rural population living in the foothills of the Himalayas. He holds a master’s degree in public health.
